{{Rsnum
|rsid=4732513
|Gene=POR
|Chromosome=7
|position=75978290
|Orientation=plus
|GMAF=0.4688
|Gene_s=POR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.4 | 47.8 | 39.8
| HCB | 39.4 | 47.4 | 13.1
| JPT | 36.3 | 44.2 | 19.5
| YRI | 46.9 | 39.5 | 13.6
| ASW | 49.1 | 38.6 | 12.3
| CHB | 39.4 | 47.4 | 13.1
| CHD | 38.5 | 47.7 | 13.8
| GIH | 8.9 | 36.6 | 54.5
| LWK | 47.3 | 45.5 | 7.3
| MEX | 46.6 | 37.9 | 15.5
| MKK | 44.2 | 50.6 | 5.1
| TSI | 20.6 | 41.2 | 38.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=24273552
|Title=A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}